Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis
Simon Witzel, André Maier, Robert Steinbach, et al.
JAMA Neurology (2022) Vol. 79, Iss. 2, pp. 121-121
Open Access | Times Cited: 142

Showing 26-50 of 142 citing articles:

Effectiveness of edaravone in preventing contrast‐induced nephropathy in high‐risk patients undergoing coronary angiography: A randomized, double‐blind trial
Azam Esmailnejad, Sepideh Zununi Vahed, Seyyedeh Mina Hejazian, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 4
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease
Charis Wong, Rachel Dakin, J Williamson, et al.
BMJ Open (2022) Vol. 12, Iss. 7, pp. e064173-e064173
Open Access | Times Cited: 19
Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus
Charis Wong, Jenna M. Gregory, Jing Liao, et al.
BMJ Open (2023) Vol. 13, Iss. 2, pp. e064169-e064169
Open Access | Times Cited: 10
Sodium Phenylbutyrate and Taurursodiol: A New Therapeutic Option for the Treatment of Amyotrophic Lateral Sclerosis
Ali Alqallaf, Drew W. Cates, Kandon P. Render, et al.
Annals of Pharmacotherapy (2023) Vol. 58, Iss. 2, pp. 165-173
Closed Access | Times Cited: 10
Exploring Advancements in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review of Current Modalities and Future Prospects
Pranvera Hoxhaj, Natasha Hastings, Meet Popatbhai Kachhadia, et al.
Cureus (2023)
Open Access | Times Cited: 10
Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases
Aaron Izenberg
CONTINUUM Lifelong Learning in Neurology (2023) Vol. 29, Iss. 5, pp. 1538-1563
Closed Access | Times Cited: 10
Cortical thickness correlated with peripheral inflammatory cytokines in amyotrophic lateral sclerosis
Jing Yang, Wenyi Li, Mei Tian, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access
ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects
Fereshte Salami, Tannaz Moeini Shad, Nazanin Fathi, et al.
Journal of Clinical Immunology (2025) Vol. 45, Iss. 1
Open Access
Novel Approaches for Treating Alzheimer’s Disease and Other Dementias
M. Catarina Silva, David C. Butler, Sally Temple, et al.
Oxford University Press eBooks (2025), pp. 797-812
Closed Access
Network Pharmacology Analysis and Experimental Validation of Tectoridin in the Treatment of Ischemic Stroke by Inhibiting Apoptosis and Regulating Inflammation
Tingting Lu, Zhen Feng, Hui Xue, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1402-1402
Open Access
Progressive Bulbar Palsy (PBP) or Bulbar Onset MND: “A Case Report”
Sagar S. Bhovare, Akhataribano Sheikh Sayyad
Journal of Pharmacy And Bioallied Sciences (2025)
Open Access
Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis
Xiaolu Liu, Huifang Shang, Qianqian Wei, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2461055-e2461055
Open Access
A positron emission tomography tracer for the imaging of oxidative stress in the central nervous system
Justin H. Wilde, Yu Sun, Spenser R. Simpson, et al.
Nature Biomedical Engineering (2025)
Open Access
Adverse events reporting of edaravone: a real-world analysis from FAERS database
Shang Qi, Jie Zhou, Junchang Ye, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Edaravone alleviates sepsis-induced diaphragmatic dysfunction via Sirt1/Nrf2 pathway
Youping Zhang, Hongkai Dai, Man Lv, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114475-114475
Closed Access
Therapeutic effect of edaravone on osteoarthritis: targeting NRF2 signaling and mitochondrial function
Chao Jiang, Yuhang Gong, Xinyu Wu, et al.
Journal of Orthopaedic Translation (2025) Vol. 52, pp. 220-232
Closed Access
Neuroferroptosis in health and diseases
Peng Lei, Tara L. Walker, Scott Ayton
Nature reviews. Neuroscience (2025)
Closed Access
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
Dmitriy Nikitin, Anil N. Makam, Kangho Suh, et al.
Journal of Managed Care & Specialty Pharmacy (2023) Vol. 29, Iss. 2, pp. 216-221
Open Access | Times Cited: 9
Edaravone for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
Shile Huang, Yinli Shen, Wenyan Peng, et al.
Acta Neurologica Belgica (2024) Vol. 124, Iss. 3, pp. 895-904
Closed Access | Times Cited: 3
Intranasal delivery of small extracellular vesicles reduces the progress of amyotrophic lateral sclerosis and the overactivation of complement-coagulation cascade and NF-ĸB signaling in SOD1G93A mice
Jinrui Zhou, Fuxiang Li, Bin Jia, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Single-nucleus RNA sequencing reveals spatiotemporal dynamics of disease-associated microglia in amyotrophic lateral sclerosis
Luxi Chen, Mei-Di Zhang, Hai-Feng Xu, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3
Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders
Fabio Arturo Iannotti
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 238-238
Open Access | Times Cited: 8
Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study
Jae‐Yong Nam, Sehwan Chun, Tae Yong Lee, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7
Sex dimorphism in the effect and predictors of weight loss after sleeve gastrectomy
Jiaxin Shu, Tao Zhu, Sisi Xiong, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
Identification and characterization of novel ERBB4 variant associated with sporadic amyotrophic lateral sclerosis (ALS)
Younghwi Kwon, Minsung Kang, Yu‐Mi Jeon, et al.
Journal of the Neurological Sciences (2024) Vol. 457, pp. 122885-122885
Closed Access | Times Cited: 2

Scroll to top